tradingkey.logo
tradingkey.logo
Search

Royalty Pharma PLC

RPRX
Add to Watchlist
58.440USD
-0.580-0.98%
Close 07-31 16:00ETQuotes delayed by 15 min
25.93BMarket Cap
30.42P/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Morgan Stanley Investment Management Inc. (US)
8.42%
Capital International Investors
7.02%
Nogra Group Sicaf SIF S.A.
5.46%
Fidelity Management & Research Company LLC
4.89%
BlackRock Institutional Trust Company, N.A.
4.01%
Other
70.20%
Shareholders
Shareholders
Proportion
Morgan Stanley Investment Management Inc. (US)
8.42%
Capital International Investors
7.02%
Nogra Group Sicaf SIF S.A.
5.46%
Fidelity Management & Research Company LLC
4.89%
BlackRock Institutional Trust Company, N.A.
4.01%
Other
70.20%
Shareholder Types
Shareholders
Proportion
Investment Advisor
43.86%
Investment Advisor/Hedge Fund
26.82%
Hedge Fund
6.35%
Corporation
5.47%
Research Firm
5.32%
Individual Investor
1.66%
Pension Fund
1.61%
Bank and Trust
1.24%
Sovereign Wealth Fund
0.83%
Other
6.84%

Institutional Shareholding

Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
1206
421.23M
95.03%
+38.55M
2025Q4
1141
352.97M
82.61%
-3.59M
2025Q3
1081
361.68M
83.67%
+1.05M
2025Q2
1050
400.70M
92.75%
+2.82M
2025Q1
1055
377.46M
89.18%
-34.89M
2024Q4
994
390.78M
89.67%
-2.48M
2024Q3
951
382.53M
85.35%
-9.94M
2024Q2
919
378.24M
83.94%
-8.34M
2024Q1
889
372.56M
83.37%
-16.43M
2023Q4
859
370.68M
82.95%
-12.48M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Morgan Stanley Investment Management Inc. (US)
37.31M
8.71%
+839.33K
+2.30%
Dec 31, 2025
Capital International Investors
31.10M
7.26%
+3.89M
+14.30%
Dec 31, 2025
Nogra Group Sicaf SIF S.A.
24.22M
5.65%
-5.70M
-19.06%
Feb 19, 2026
Fidelity Management & Research Company LLC
21.67M
5.06%
-1.33M
-5.80%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
17.79M
4.15%
+536.61K
+3.11%
Dec 31, 2025
Baillie Gifford & Co.
17.01M
3.97%
-363.73K
-2.09%
Dec 31, 2025
Morgan Stanley & Co. LLC
12.86M
3%
+9.85M
+326.86%
Dec 31, 2025
Adage Capital Management, L.P.
11.74M
2.74%
-225.04K
-1.88%
Dec 31, 2025
Swedbank Robur Fonder AB
11.94M
2.79%
-258.13K
-2.12%
Dec 31, 2025
State Street Investment Management (US)
10.65M
2.49%
+376.89K
+3.67%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Formidable ETF
6.39%
Invesco Biotechnology & Genome ETF
5.08%
iShares U.S. Pharmaceuticals ETF
4.58%
VictoryShares Free Cash Flow ETF
3%
State Street SPDR S&P Pharmaceuticals ETF
2.71%
Bushido Capital US Equity ETF
2.32%
ALPS O'Shares US Small-Cap Quality Dividend ETF
1.99%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.92%
ProShares Ultra Nasdaq Biotechnology
1.59%
Invesco Nasdaq Biotechnology ETF
1.58%
View more
Formidable ETF
Proportion6.39%
Invesco Biotechnology & Genome ETF
Proportion5.08%
iShares U.S. Pharmaceuticals ETF
Proportion4.58%
VictoryShares Free Cash Flow ETF
Proportion3%
State Street SPDR S&P Pharmaceuticals ETF
Proportion2.71%
Bushido Capital US Equity ETF
Proportion2.32%
ALPS O'Shares US Small-Cap Quality Dividend ETF
Proportion1.99%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion1.92%
ProShares Ultra Nasdaq Biotechnology
Proportion1.59%
Invesco Nasdaq Biotechnology ETF
Proportion1.58%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.